×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VOR – vor biopharma inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VOR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/1
05:00 pm
vor
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3/31
10:43 am
vor
Vor Biopharma (VOR) had its price target raised by Wedbush from $9.00 to $15.00. They now have a "neutral" rating on the stock.
Medium
Report
Vor Biopharma (VOR) had its price target raised by Wedbush from $9.00 to $15.00. They now have a "neutral" rating on the stock.
3/31
06:24 am
vor
Vor Biopharma (VOR) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
High
Report
Vor Biopharma (VOR) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
3/30
08:43 am
vor
Vor Biopharma (VOR) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
Vor Biopharma (VOR) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $50.00 price target on the stock.
3/30
08:01 am
vor
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Low
Report
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
3/30
08:00 am
vor
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
Low
Report
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
3/27
08:00 am
vor
Vor Bio Announces $75 Million Private Placement with TCGX
Medium
Report
Vor Bio Announces $75 Million Private Placement with TCGX
3/23
04:30 pm
vor
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
05:29 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: TCG Crossover GP II, LLC
Medium
Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: TCG Crossover GP II, LLC
4/1
05:16 pm
vor
Form 3 Vor Biopharma Inc. For: Mar 30 Filed by: TCG Crossover GP III, LLC
Medium
Report
Form 3 Vor Biopharma Inc. For: Mar 30 Filed by: TCG Crossover GP III, LLC
4/1
05:10 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
3/30
08:03 am
vor
Form 10-K Vor Biopharma Inc. For: Dec 31
Low
Report
Form 10-K Vor Biopharma Inc. For: Dec 31
3/27
08:03 am
vor
Form 8-K Vor Biopharma Inc. For: Mar 26
Low
Report
Form 8-K Vor Biopharma Inc. For: Mar 26
3/16
04:15 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
2/17
07:00 pm
vor
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Verve Capital Ltd
Low
Report
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Verve Capital Ltd
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: